Efficacy and safety of ustekinumab in the treatment of moderate to severe plaque psoriasis in Singapore by Wai Sze Agnes Chan, Yisheng Wong, Hazel Hwee Boon Oon, Colin Thiam Seng Theng, Wei-Sheng Chong

Subjects: “…biologic…”
Get full text

Real-life Experience of Bimekizumab in 27 Obese Patients With Plaque-type Psoriasis: a 24-week Multicenter Retrospective Study by Zeno Fratton, Vincenzo Maione, Stefano Bighetti, Luca Bettolini, Giuseppe Stinco, Enzo Errichetti

Subjects: Get full text

Epidemiology and Treatment Patterns of Fistulizing Crohn’s Disease in a Large, Real-World Australasian Cohort by Jack McNamara, William Wilson, Joseph L. Pipicella, Simon Ghaly, Jakob Begun, Ian C. Lawrance, Richard Gearry, Jane M. Andrews, Susan J. Connor

Subjects: Get full text

South African Rheumatism and Arthritis Association 2024 guidelines for the use of biologic and targeted synthetic disease-modifying antirheumatic drugs by E van Duuren, J Potts, U Brijlal, S Botha, S Didi, K Makan, M van Dam, K Chinniah, B Hodkinson

Subjects: Get full text

Ten-Year Persistence of Biologic Drugs in Psoriasis and Its Relationship with Pharmacogenetic Biomarkers by Andrea Rodríguez-Lopez, María Martínez-Sendino, Rocío Prieto-Pérez, Paula Soria-Chacartegui, Eva González-Iglesias, Mario Aparicio-Domínguez, Sonsoles Berenguer-Ruiz, Esteban Daudén, Francisco Abad-Santos

Subjects: Get full text

Mathematical insights on psoriasis regulation: Role of Th1 and Th2 cells by Amit Kumar Roy, Priti Kumar Roy, Ellina Grigorieva

Subjects: Get full text

Portuguese consensus on first line treatment of moderate-to-severe psoriasis with a non-TNF inhibitor therapy – a delphi methodology by Tiago Torres, Sofia Magina, Maria João Paiva Lopes

Subjects: Get full text

Inter-laboratory Comparison between Particle and Bacterial Filtration Efficiencies of Medical Face Masks in the COVID-19 Context by Axel Fouqueau, Jérémie Pourchez, Lara Leclerc, Aurélien Peyron, Yoann Montigaud, Paul Verhoeven, Tatiana Macé, Alexandre Bescond, Dominique Thomas, Augustin Charvet, Mathieu Ghijselings, Pauline Hars, Franck Polyn, François Gaie-Levrel

Subjects: Get full text

A year in review: new treatments and expanded indications in dermatology in 2024 by Lauren N. McGrath, Lila G. McGrath, John R. Edminister

Subjects: Get full text

Nematode controlling effects and safety tests of Duddingtonia flagrans biological preparation in sheep by Yuan Ma, Lili Jiang, Zhaobin Fan, Luyao Hao, Zhengyi Li, Yanni Zhang, Qiannan Li, Rui Wang, Hongliang Luo

Subjects: “…Lyophilized biologic…”
Get full text

Biologics for eosinophilic oesophagitis: a systematic review and meta-analysis by Beibei Zeng, Doudou Jia, Shengen Li, Xuna Liu, Boxu Zhu, Yanqi Zhang, Yan Zhuang, Fei Dai

Subjects: Get full text

Ulcerative colitis: STRIDE-ing beyond symptoms with new standards by Shu Wen Tay, Kevin Kim Jun Teh, Tiing-Leong Ang, Malcolm Tan

Subjects: “…biologic therapy…”
Get full text

Biologic Therapy and Cardiometabolic Risk in Psoriasis: A Retrospective Review by Annika Smith, Aidin Karahasan, Deborah Yi, Sanjay Yapabandara, James Elhindi, Pablo Fernandez-Penas, Clara Chow, Sarah Zaman

Subjects: Get full text

Evaluation of Biologics ACE2/Ang(1–7) Encapsulated in Plant Cells for FDA Approval: Safety and Toxicology Studies by Henry Daniell, Geetanjali Wakade, Smruti K. Nair, Rahul Singh, Steven A. Emanuel, Barry Brock, Kenneth B. Margulies

Subjects: “…biologic…”
Get full text

The research progress of biologics in elderly-onset rheumatoid arthritis (EORA) by Yujie Li, Yifan Liu, Yanhui Tian, Huimin Gu, Qingliang Meng, Jiakang Cui, Junfu Ma

Subjects: Get full text

Introduction to the South African Rheumatism and Arthritis Association 2024 guidelines by B Hodkinson, E van Vuuren, A Maharaj, F Paruk, K Makan

Subjects: Get full text

NATURAL MUTAGENESIS AS A POSSIBLE CAUSAL FACTOR FOR OCCURRENCE OF OBLIGATE EMBRYONIC DIAPAUSE IN MAMMALS (A HYPOTHESIS) by G. K. Isakova

Subjects: Get full text

Systematic review and bayesian network meta-analysis: comparative efficacy and safety of six commonly used biologic therapies for moderate-to-severe Crohn’s disease by Haohang Su, Haohang Su, Shengwei Xiao, Zhiqing Liang, Zhiqing Liang, Tianrong Xun, Jinfang Zhang, Jinfang Zhang, Xixiao Yang, Xixiao Yang

Subjects: Get full text

Management of tuberculosis risk, screening and preventive therapy in patients with chronic autoimmune arthritis undergoing biotechnological and targeted immunosuppressive agents by Andrea Picchianti-Diamanti, Alessandra Aiello, Chiara De Lorenzo, Giovanni Battista Migliori, Delia Goletti

Subjects: Get full text

Efficacy and safety of conventional synthetic, biologic, and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis-interstitial lung disease: A narrative... by Richard Conway, Luke Corcoran, Elena Nikiphorou

Subjects: “…biologic disease-modifying antirheumatic drugs…”
Get full text